Email updates

Keep up to date with the latest news and content from BMC Infectious Diseases and BioMed Central.

Open Access Highly Accessed Research article

Diagnosis of latent tuberculosis infection among HIV discordant partners using interferon gamma release assays

Naasha J Talati1*, Esteban Gonzalez-Diaz2, Charles Mutemba3, Joyanna Wendt4, William Kilembe3, Lawrence Mwananyanda3, Elwyn Chomba3, Susan Allen35, Carlos del Rio45 and Henry M Blumberg45

Author Affiliations

1 Department of Medicine, University of Pennsylvania, Philadelphia, PA 19019, USA

2 Department of Medicine, Hospital Civil de Guadalajara, Guadalajara 44280, Mexico

3 Zambia Emory HIV Research Project, Lusaka, Zambia

4 Department of Medicine, Emory University, Atlanta 30329, USA

5 Rollins School of Public Health, Emory University, Atlanta 30329, USA

For all author emails, please log on.

BMC Infectious Diseases 2011, 11:264  doi:10.1186/1471-2334-11-264

Published: 30 September 2011

Abstract

Background

There is limited data on the effect of HIV status and CD4 counts on performance of Interferon-g Release assays (IGRAs) for diagnosis of latent tuberculosis infection (LTBI).

Methods

A cross sectional study was conducted to assess the prevalence of and risk factors for a positive diagnostic test for LTBI, using tuberculin skin test (TST) and IGRAs among HIV-discordant couples in Zambia.

Results

A total of 596 subjects (298 couples) were enrolled. Median CD4 count among HIV positive persons was 388 cells/μl, (range 51-1330). HIV negative persons were more likely than their HIV positive partner, to have a positive diagnostic test for LTBI with TST (203 vs 128), QFT (171 vs 109) and TSPOT (156 vs. 109). On multivariate analysis, HIV negative status was an independent predictor for a positive QFT (OR = 2.22, 95% CI 1.42- 3.46) and TSPOT (OR = 1.79, 95% CI 1.16-2.77). Among HIV positive subjects a CD4 count ≥ 388 cells/μl was associated with a positive TST (OR = 1.76 95% CI 1.10-2.82) and QFT (OR = 1.71 95% CI 1.06-2.77) but not TSPOT (OR = 1.20 95% CI 0.74-1.94).

Conclusions

Persons with HIV had significantly fewer positive diagnostic tests for LTBI with TST, QFT and TSPOT. Persons with a CD4 count < 388 cells/μl were less likely to have a positive TST or QFT, but not less likely to have a positive TSPOT. TSPOT may perform better than TST or QFT in HIV positive individuals.